Literature DB >> 20448280

Current evidence for a strategic approach to the management of rheumatoid arthritis with disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis.

R Knevel1, M Schoels, T W J Huizinga, D Aletaha, G R Burmester, B Combe, R B Landewé, J S Smolen, T Sokka, D M F M van der Heijde.   

Abstract

OBJECTIVES: To perform a systematic literature review of effective strategies for the treatment of rheumatoid arthritis (RA).
METHODS: As part of a European League Against Rheumatism (EULAR) Task Force investigation, a literature search was carried out from January 1962 until February 2009 in PubMed/Ovid Embase/Cochrane and EULAR/American College of Rheumatism (ACR)) abstracts (2007/2008) for studies with a treatment strategy adjusted to target a predefined outcome. Articles were systematically reviewed and clinical outcome, physical function and structural damage were compared between intensive and less intensive strategies. The results were evaluated by an expert panel to consolidate evidence on treatment strategies in RA.
RESULTS: The search identified two different kinds of treatment strategies: strategies in which the reason for treatment adjustment differed between the study arms ('steering strategies', n=13) and strategies in which all trial arms used the same clinical outcome to adjust treatment with different pharmacological treatments ('medication strategies', n=7). Both intensive steering strategies and intensive medication strategies resulted in better outcome than less intensive strategies in patients with early active RA.
CONCLUSION: Intensive steering strategies and intensive medication strategies produce a better clinical outcome, improved physical function and less structural damage than conventional steering or treatment. Proof in favour of any steering method is lacking and the best medication sequence is still not known.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20448280     DOI: 10.1136/ard.2009.126748

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  34 in total

1.  Rheumatoid arthritis: Guidelines for RA therapy-avoiding hamartia.

Authors:  Arthur Kavanaugh
Journal:  Nat Rev Rheumatol       Date:  2010-09       Impact factor: 20.543

2.  The risk of serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors decreased over time: a report from the registry of Japanese rheumatoid arthritis patients on biologics for long-term safety (REAL) database.

Authors:  Ryoko Sakai; Soo-Kyung Cho; Toshihiro Nanki; Ryuji Koike; Kaori Watanabe; Hayato Yamazaki; Hayato Nagasawa; Koichi Amano; Yoshiya Tanaka; Takayuki Sumida; Atsushi Ihata; Shinsuke Yasuda; Atsuo Nakajima; Takahiko Sugihara; Naoto Tamura; Takao Fujii; Hiroaki Dobashi; Yasushi Miura; Nobuyuki Miyasaka; Masayoshi Harigai
Journal:  Rheumatol Int       Date:  2014-05-23       Impact factor: 2.631

3.  Creative trial design in RA: optimizing patient outcomes.

Authors:  Maya H Buch; Sue Pavitt; Mahesh Parmar; Paul Emery
Journal:  Nat Rev Rheumatol       Date:  2013-02-05       Impact factor: 20.543

4.  Barriers to achieving controlled rheumatoid arthritis in the United Arab Emirates: a cross-sectional study.

Authors:  Mira Noura Moufarrej; Ziyad Mahfoud; Humeira Badsha
Journal:  Rheumatol Int       Date:  2014-10-15       Impact factor: 2.631

Review 5.  Rheumatoid arthritis: previously untreated early disease.

Authors:  Wiranthi M A Gunasekera; John R Kirwan
Journal:  BMJ Clin Evid       Date:  2016-08-01

6.  A multicenter, randomized, double-blind clinical trial of combination therapy with Anbainuo, a novel recombinant human TNFRII:Fc fusion protein, plus methotrexate versus methotrexate alone or Anbainuo alone in Chinese patients with moderate to severe rheumatoid arthritis.

Authors:  Xiao-Xiang Chen; Qing Dai; An-Bin Huang; Hua-Xiang Wu; Dong-Bao Zhao; Xing-Fu Li; Shao-Xian Hu; Nan-Ping Yang; Yi Tao; Jian-Hua Xu; Lin-Di Jiang; Chun-De Bao
Journal:  Clin Rheumatol       Date:  2012-10-04       Impact factor: 2.980

7.  A public health approach to addressing arthritis in older adults: the most common cause of disability.

Authors:  Jennifer M Hootman; Charles G Helmick; Teresa J Brady
Journal:  Am J Public Health       Date:  2012-01-19       Impact factor: 9.308

8.  Spectacular improvement in vitamin D status in elderly osteoporotic women: 8-year analysis of an osteoporotic population treated in a dedicated fracture liaison service.

Authors:  A Amouzougan; A Deygat; B Trombert; E Constant; D Denarié; H Marotte; T Thomas
Journal:  Osteoporos Int       Date:  2015-06-24       Impact factor: 4.507

Review 9.  Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis: A network meta-analysis.

Authors:  Glen S Hazlewood; Cheryl Barnabe; George Tomlinson; Deborah Marshall; Daniel J A Devoe; Claire Bombardier
Journal:  Cochrane Database Syst Rev       Date:  2016-08-29

Review 10.  EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs.

Authors:  Josef S Smolen; Robert Landewé; Ferdinand C Breedveld; Maxime Dougados; Paul Emery; Cecile Gaujoux-Viala; Simone Gorter; Rachel Knevel; Jackie Nam; Monika Schoels; Daniel Aletaha; Maya Buch; Laure Gossec; Tom Huizinga; Johannes W J W Bijlsma; Gerd Burmester; Bernard Combe; Maurizio Cutolo; Cem Gabay; Juan Gomez-Reino; Marios Kouloumas; Tore K Kvien; Emilio Martin-Mola; Iain McInnes; Karel Pavelka; Piet van Riel; Marieke Scholte; David L Scott; Tuulikki Sokka; Guido Valesini; Ronald van Vollenhoven; Kevin L Winthrop; John Wong; Angela Zink; Désirée van der Heijde
Journal:  Ann Rheum Dis       Date:  2010-05-05       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.